Screener
LifeStance Health Group LFST Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 4.9%+5.0pp | 3%+4.1pp | 1.7%+4.3pp | 0.4%+5.8pp | -0.1%+12.0pp | |
| Net margin | 3.2%+3.9pp | 1.6%+3.8pp | 0.7%+4.7pp | -0.7%+6.7pp | -0.7%+12.3pp | |
| Returns | ||||||
| Return on equity | 3.4%+4.1pp | 1.6%+3.6pp | 0.7%+4.2pp | -0.6%+5.5pp | -0.7%+9.7pp | |
| Return on invested capital | 3.4%+3.5pp | 1.7%+2.5pp | 1.1%+2.9pp | 0.3%+3.8pp | -0.1%+7.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.1× | 0.7×+0.1× | 0.7×+0.1× | 0.6×+0.1× | 0.6×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.4×-0.1× | 1.5×0.0× | 1.7×+0.3× | 1.6×+0.3× | 1.5×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Net debt / EBITDA | 1.9×-3.2× | 2.8×-4.4× | 2.9×-5.8× | 4.3×-24.2× | 5.1×— | |
| Per Share | ||||||
| Book value per share | $3.81+0.1% | $3.74+0.3% | $3.89+1.9% | $3.84+1.6% | $3.81+1.1% | |
| Valuation | ||||||
| Market capitalization | $4.07B+168% | $2.44B-4.8% | $2.74B-2.9% | $2.14B-19.5% | $1.98B+6.9% | |
| Price / earnings | 80.4×— | 105.1×— | 283.4×— | —— | —— | |
| Price / sales | 2.6×+1.4× | 1.6×-0.4× | 1.9×-0.3× | 1.6×-0.6× | 1.5×-0.1× | |
| Price / book | 2.8×+1.7× | 1.7×-0.1× | 1.8×-0.1× | 1.4×-0.4× | 1.3×0.0× | |
| EV / EBITDA | 32.5×+0.4× | 27.4×-33.4× | 37.6×-44.7× | 38.8×-186× | 40.2×— |
FAQ
- Where do LifeStance Health Group's ratios come from?
- Every ratio is computed from LifeStance Health Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
